⌘K

Home/Filings/4/0001213900-19-026862

4//SEC Filing

Ence Chuck 4

Accession 0001213900-19-026862

CIK 0001553643other

View on SEC.gov Company Profile

Filed

Dec 22, 7:00 PM ET

Accepted

Dec 23, 5:00 PM ET

Size

5.3 KB

Accession

0001213900-19-026862

Insider Transaction Report

Form 4

Period: 2019-12-19

RELMADA THERAPEUTICS, INC.RLMD

CAO and COO

Transactions

Award
Options to purchase common stock
2019-12-19$43.47/sh+60,000$2,608,200→ 60,000 total
Exercise: $43.47Exp: 2029-12-19→ Common Stock (60,000 underlying)

Footnotes (1)

[F1]Pursuant to the terms of the company's 2014 Stock Option and Equity Incentive Plan, 6.25% of the options shall vest each quarter from the date of grant.

Documents

1 file

4
ownership.xmlPrimary

Issuer

RELMADA THERAPEUTICS, INC.

CIK 0001553643

Entity typeother

Related Parties

1

filerCIK 0001697779

Filing Metadata

Form type: 4
Filed: Dec 22, 7:00 PM ET
Accepted: Dec 23, 5:00 PM ET
Size: 5.3 KB

View on SEC.gov